This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
4/21/2026
Jane Lowe
Moderator
Welcome to the Lumos Diagnostics Investor Briefing to discuss the Q3 FY26 results that were lodged with the ASX yesterday. My name is Jane Lowe, and I'll be your moderator for this session. With us this morning, we have Lumos Diagnostics Chairman, Sam Lanyon. I'll say good morning to you, Sam.
Sam Lanyon
Chairman
Morning, Jane.
Jane Lowe
Moderator
Good morning. Also CEO and Managing Director, Doug Ward. Afternoon to you.
You're reading a preview of the LDX.AX Q3 2026 earnings call.
Free account.
Disclaimer